TECH Q1'27 Earnings: EPS estimate is 0.44 USD

What happened

Bio-Techne is scheduled to announce its Q1'27 results on November 03, with the release expected at 7:00 AM ET. The supplied estimates put revenue at 292.60 million USD and earnings per share, or EPS, at 0.44 USD.

Confirmed

Global impact / market context

The reported figures will show whether Bio-Techne’s sales and earnings matched the estimates. Revenue above or below 292.60 million USD can indicate stronger or weaker demand, while EPS relative to 0.44 USD signals how sales, costs, and share count translated into profit for investors.

Analyst inference

The supplied history shows quarterly revenue estimates and reported sales have differed in both directions, while EPS estimates have also been exceeded or missed. This makes the upcoming comparison useful, but the article provides no guidance, explanation for past gaps, or market reaction.

Analyst inference

What to watch

1. Check the announced revenue against the 292.60 million USD estimate; a shortfall or beat would show whether reported sales were weaker or stronger than expected. Confirmed
2. Compare reported EPS with 0.44 USD and look for any company explanation of changes in costs or earnings, which could clarify profit per share. Confirmed
3. Watch for any outlook or business commentary alongside results; changes in expected demand or spending could shape future revenue and costs, but none is provided here. Analyst inference

Evidence

• Original source link unavailable